Abstract
Whole genome sequencing and alendronate may be of value in diagnosing and managing CED, respectively.
| Original language | English |
|---|---|
| Pages (from-to) | 6427-6429 |
| Number of pages | 3 |
| Journal | Rheumatology |
| Volume | 64 |
| Issue number | 12 |
| Early online date | 14 Aug 2025 |
| DOIs | |
| Publication status | Published - 1 Dec 2025 |
Bibliographical note
Copyright © 2025, © The Author(s) 2025. Published by Oxford University Press on behalf of the British Society for Rheumatology.Fingerprint
Dive into the research topics of 'Identification of a novel TGFB1 variant in a patient with Camurati-Engelmann disease responsive to alendronate'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver